Clinical trial · Observational
Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors
Investigating the Feasibility of Using Real-time Cine-MRI for Treating Moving and Deforming Tumors
NCT01071434CI-TRIAL-00008625terminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): PI left
Summary
Brief summary (as posted)
This study aims to investigate and optimize imaging sequences and parameters of rapid real-time MRI in order to obtain adequate guidance for accurately and precisely delivering radiation to moving abdominal and thoracic tumors.
Conditions
Conditions (10)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatobiliary Cancers | Malignant Hepatobiliary Neoplasm | ALIAS | 0.90 |
| Hepatobiliary Cancers Bile Duct | — | UNRESOLVED | — |
| Hepatobiliary Cancers Gallbladder | — | UNRESOLVED | — |
| Hepatobiliary Cancers Hepatocellular Carcinoma (Hepatoma) | Hepatocellular Carcinoma | ALIAS | 0.85 |
| Hepatobiliary Cancers Liver | — | UNRESOLVED | — |
| Liver Cancer | Malignant Liver Neoplasm | CURATED_EXACT | 0.92 |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Lung Cancer Non-Small Cell Cancer (NSCLC) | Lung Non-Small Cell Carcinoma | ALIAS | 0.85 |
| Lung Cancer Small Cell Lung Cancer (SCLC) | Lung Small Cell Carcinoma | ALIAS |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| MR Imaging | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- investigate and optimize imaging sequences and parameters of rapid real-time MRI in order to obtain adequate guidance for accurately and precisely delivering radiation to moving abdominal and thoracic tumors.
- timeFrame
- two hours
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria:3.1.1. Eligible disease(s)/stage(s) \\AJCC Stage I, II, III or IV lung, liver or pancreatic cancer of any histology to be treated using radiotherapy will be eligible for this study. 3.1.2. Allowable type and amount of prior therapy \ Any types and amounts of prior therapy will be allowed for this study. 3.1.3. Age restriction and/or gender/ethnic restrictions \\Patients must be greater than or equal to 18 years of age. There are no gender or ethnic restrictions. 3.1.4. Life expectancy restrictions \ None. 3.1.5. ECOG or Karnofsky Performance Status \ Karnofsky performance status of 50 or greater 3.1.6. Requirements for organ and marrow function \ None. 3.1.7. Ability to understand and the willingness to sign a written informed consent document. 3.1.8. Pain-free in supine position Exclusion Criteria:3.2.1 Children (age \<18) 3.2.2 Metallic implants, embedded metallic objects, implanted biomedical devices e.g., cardiac pacemakers 3.2.3 Women who are pregnant or trying to get pregnant 3.2.4 Pain in supine position 3.2.5 Karnofsky performance status \< 50
References
Publications (0)
Data not yet available
No reference posted for this study.